Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A
8(100.0%)
8Total
N/A(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT03259373Not ApplicableCompleted

IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation

Role: collaborator

NCT06066541Not ApplicableCompleted

Social Norms, Messengers, and Processing Fluency to Increase Hypertension Medication Adherence

Role: collaborator

NCT01651208Not ApplicableCompleted

Improving Adherence to Post PCI Antiplatelet Therapy in Minority Populations

Role: collaborator

NCT05161429Unknown

BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

Role: collaborator

NCT04862858Not ApplicableUnknown

Educational Intervention to Increase Select Guideline-recommended Cardioprotective Medications in Patients With Diabetes

Role: lead

NCT02697916Not ApplicableCompleted

Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term

Role: collaborator

NCT02469402Not ApplicableCompleted

Nutritive Efficacy and Safety of a Modified Infant Formula With a Reduced Protein Content and Improved Protein Quality

Role: collaborator

NCT02037685Not ApplicableCompleted

Improving Adherence to Statins Among Minority Populations

Role: collaborator

NCT01603329Not ApplicableCompleted

Increasing Medication Adherence Through Physician Incentives and Messaging

Role: collaborator

All 9 trials loaded